Defending Domestic Orange Juice Production Act of 2025

The Defending Domestic Orange Juice Production Act of 2025 (HR933) was introduced on February 4, 2025, by Rep. Scott Franklin (R-FL) with 25 bipartisan cosponsors, all from Florida. The bill is currently in early legislative stages, having been referred to the House Committee on Energy and Commerce. The bill's mechanism is straightforward regulatory relief: it amends the FDA's standard of identity for pasteurized orange juice to require 10.0% orange juice soluble solids by weight instead of the current 10.5%. This 0.5 percentage point reduction cuts the required raw orange juice concentrate input by approximately 4.8%. The bill does not authorize or appropriate any government funding — it is a pure regulatory standard change that directly lowers raw ingredient costs for OJ producers. Structural winners are the three major publicly traded beverage companies with significant US orange juice operations: PepsiCo ($PEP) through its Tropicana brand (the largest US OJ brand), Coca-Cola ($KO) through Minute Maid and Simply, and Keurig Dr Pepper ($KDP) through Mott's. Tropicana and Minute Maid carry the largest OJ volume exposure, making $PEP and $KO the most leveraged beneficiaries. This is a cost-side improvement — not a demand driver — meaning it directly expands gross margins on OJ product lines without requiring any consumer behavior change. The legislative path remains uncertain: the bill is early-stage with no committee hearings or markup scheduled. However, the companion bill S1251 was also introduced in the Senate and referred to HELP Committee, indicating bicameral interest. The Florida delegation's unified support (all 25 cosponsors are from Florida) reflects the state's dominant role in US orange production, but the narrow geographic sponsorship suggests limited national momentum. Passage probability is moderate if attached to a broader FDA or agriculture package. Recent market data shows $KO at $78.80 (near 52-week high of $82), up 3.62% over 30 days; $PEP at $157.74 (mid-range), up 1.58% over 30 days; and $KDP at $29.23, up 11.01% over 30 days. These moves appear driven by broader market and sector trends rather than HR933 specifically, as the bill has no new legislative actions since February 2025.